We are live on ! Find out more
BJ

BlackRock Japan Portfolio holdings

AUM $30.3B
1-Year Est. Return 13.85%
This Fund
S&P 500
This Quarter Est. Return
+1.94%
1 Year Est. Return
+13.85%
3 Year Est. Return
+34.02%
5 Year Est. Return
10 Year Est. Return
AUM
$25B
AUM Growth
-$1.1B
Cap. Flow
-$1.34B
Cap. Flow %
-5.34%
Top 10 Hldgs %
15.82%
Holding
1,477
New
152
Increased
260
Reduced
806
Closed
183

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$32.6M
2
AGN
Allergan plc
AGN
+$32M
3
SPG icon
Simon Property Group
SPG
+$17M
4
ALKS icon
Alkermes
ALKS
+$13M
5
QRVO icon
Qorvo
QRVO
+$12.7M

Sector Composition

Rank Sector Weight
1 Healthcare 15.23%
2 Technology 14.34%
3 Financials 13.93%
4 Industrials 9.45%
5 Consumer Discretionary 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNCA
1101
DELISTED
Genocea Biosciences, Inc.
GNCA
$40K ﹤0.01%
+427
New +$30.1K
CASC
1102
DELISTED
Cascadian Therapeutics, Inc.
CASC
$40K ﹤0.01%
+4,121
New +$40.4K
COVS
1103
DELISTED
Covisint Corporation
COVS
$40K ﹤0.01%
+19,739
New +$46K
EXL
1104
DELISTED
EXCEL TRUST , INC COM STK
EXL
$40K ﹤0.01%
2,819
-306
-10% -$4.25K
AVIV
1105
DELISTED
AVIV REIT INC COM STK (MD)
AVIV
$40K ﹤0.01%
1,088
-222
-17% -$8.22K
CSR
1106
Centerspace
CSR
$921M
$39K ﹤0.01%
525
-86
-14% -$6.78K
REXR icon
1107
Rexford Industrial Realty
REXR
$8.42B
$39K ﹤0.01%
2,485
+352
+17% +$5.64K
TRVN
1108
DELISTED
Trevena, Inc.
TRVN
$39K ﹤0.01%
9
-2
-18% -$7.34K
ECYT
1109
DELISTED
Endocyte, Inc. Common Stock
ECYT
$39K ﹤0.01%
6,180
RXDX
1110
DELISTED
Ignyta, Inc.
RXDX
$39K ﹤0.01%
3,958
AGIO icon
1111
Agios Pharmaceuticals
AGIO
$1.79B
$38K ﹤0.01%
398
-2,137
-84% -$239K
CARM
1112
DELISTED
Carisma Therapeutics
CARM
$38K ﹤0.01%
+213
New +$46.5K
ALR
1113
DELISTED
AlerisLife Inc
ALR
$38K ﹤0.01%
845
+501
+146% +$18.9K
ADMS
1114
DELISTED
Adamas Pharmaceuticals
ADMS
$38K ﹤0.01%
+2,155
New +$36.9K
WIT icon
1115
Wipro
WIT
$19.6B
$37K ﹤0.01%
15,008
ENZN
1116
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
$37K ﹤0.01%
35,231
BLUE
1117
DELISTED
bluebird bio
BLUE
$36K ﹤0.01%
23
+11
+92% +$14.5K
PAHC icon
1118
Phibro Animal Health
PAHC
$1.47B
$36K ﹤0.01%
+1,010
New +$32.5K
SPPI
1119
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$36K ﹤0.01%
5,911
BRSS
1120
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
$36K ﹤0.01%
2,305
+436
+23% +$6.05K
LOXO
1121
DELISTED
Loxo Oncology, Inc
LOXO
$36K ﹤0.01%
2,922
-441
-13% -$5.49K
PACD
1122
DELISTED
Pacific Drilling S A
PACD
$36K ﹤0.01%
+935
New +$34.6K
XIFR
1123
XPLR Infrastructure LP
XIFR
$1.12B
$35K ﹤0.01%
+796
New +$31.7K
NEFF
1124
DELISTED
Neff Corporation
NEFF
$35K ﹤0.01%
+3,320
New +$32.3K
EPRS
1125
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
$35K ﹤0.01%
+3,940
New +$31.6K

Similar funds

BlackRock Japan's Q1 2015 Portfolio in Review

As of Q1 2015, BlackRock Japan held 1,477 positions worth $25B, down 4.2% from $26.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

BlackRock Japan withdrew a net $1.34B in Q1 2015, closing 183 positions and reducing 806 holdings. Its most notable exit was Allergan Inc, an estimated $80.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, BlackRock Japan opened a new position in Qorvo worth $14.3M.

  • BlackRock Japan's largest Q1 2015 buy was Qorvo: 178,918 shares worth $14.3M.
  • BlackRock Japan added most to Medtronic in Q1 2015, an estimated $32.6M increase.
  • BlackRock Japan's biggest Q1 2015 reduction was Alphabet (Google) Class C, cutting an estimated $61.5M.
  • BlackRock Japan fully exited Allergan Inc in Q1 2015, selling an estimated $80.1M.
  • BlackRock Japan's ten largest holdings make up 16% of its $25B portfolio in Q1 2015.
  • BlackRock Japan opened 152 new positions and closed 183 in Q1 2015.
  • BlackRock Japan's portfolio value fell 4.2% quarter-over-quarter to $25B.

Based on BlackRock Japan's 13F filing for Q1 2015, filed 13 May 2015.